8-K: Integrated BioPharma Changes Certifying Accountant: Marcum LLP Replaced by CBIZ CPAs

Integrated BioPharma, Inc. announces the resignation of Marcum LLP as its independent registered public accounting firm and the engagement of CBIZ CPAs, effective April 24, 2025.

Summary

• Integrated BioPharma, Inc. has changed its independent registered public accounting firm.
• Marcum LLP resigned on April 24, 2025.
• CBIZ CPAs was engaged as the new independent registered public accounting firm, effective immediately on April 24, 2025.
• The Audit Committee of the Company's Board of Directors approved the engagement of CBIZ CPAs.
• Marcum's reports on the company's financial statements for the fiscal years ended June 30, 2024 and 2023 did not contain any adverse opinions, disclaimers, or qualifications.
• There were no disagreements between the Company and Marcum on accounting principles, financial statement disclosure, or auditing scope during the relevant periods.
• There were no reportable events as defined in Regulation S-K during the fiscal years ended June 30, 2024 and 2023, and the subsequent interim period through April 24, 2025.
• The Company did not consult with CBIZ CPAs on accounting principles or audit opinions prior to their engagement.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The change in auditors appears to be a routine matter due to an acquisition, and there are no reported disagreements or issues.

Positives

• Marcum's audit reports for the fiscal years ended June 30, 2024 and 2023 were clean, with no adverse opinions or disclaimers.
• No disagreements or reportable events occurred between Integrated BioPharma and Marcum during the relevant periods.
• The transition to CBIZ CPAs was approved by the Audit Committee of the Board of Directors.

Risks

• A change in accounting firms can sometimes signal underlying issues, though the document states there were no disagreements or reportable events.

Future Outlook

The company will rely on CBIZ CPAs for auditing services for the year ending June 30, 2025.

Industry Context

Changes in auditors are not uncommon, but investors often scrutinize the reasons behind such changes. In this case, it appears to be due to an acquisition of Marcum's attest business by CBIZ CPAs.

Comparison to Industry Standards

• Auditor changes are a regular occurrence in the corporate world.
• Companies like Teva Pharmaceutical Industries Ltd and Mylan N.V. (now Viatris) have also experienced auditor changes, often driven by mergers, acquisitions, or strategic realignments.
• The key is whether the change is accompanied by any disagreements or reportable events, which, according to the filing, is not the case here.

Stakeholder Impact

• Shareholders may want to monitor future filings to ensure a smooth transition with the new accounting firm.
• Employees in the finance department will be working with a new auditing team.

Key Dates

Keywords

accounting firm, CBIZ CPAs, Marcum LLP, independent auditor, audit committee, financial statements, Integrated BioPharma